19#iSCLife®-CI

human umbilical cord mesenchymal stem cell therapy · Sclnow Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 19#iSCLife®-CI, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. [Phase 1, Phase 2]

See pricing